Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors.

[1]  S. Knuutila,et al.  DNA sequence copy number increase at 8q: A potential new prognostic marker in high‐grade osteosarcoma , 1999, International journal of cancer.

[2]  D. Gisselsson,et al.  Chromosomal organization of amplified chromosome 12 sequences in mesenchymal tumors detected by fluorescence in situ hybridization , 1998, Genes, chromosomes & cancer.

[3]  O. Larsson,et al.  Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization , 1998, Genes, chromosomes & cancer.

[4]  S. Knuutila,et al.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.

[5]  W. Gerald,et al.  EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Fletcher,et al.  Frequency and implications of chromosome 8 and 12 gains in Ewing sarcoma. , 1998, Cancer genetics and cytogenetics.

[7]  S. Knuutila,et al.  Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. , 1997, The American journal of pathology.

[8]  H. Grier.  The Ewing family of tumors. Ewing's sarcoma and primitive neuroectodermal tumors. , 1997, Pediatric clinics of North America.

[9]  S. Ferrari,et al.  Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[11]  S. Knuutila,et al.  Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas. , 1997, The American journal of pathology.

[12]  H. Strander,et al.  Chemotherapy for osteosarcoma and Ewing's sarcoma. , 1997, Acta orthopaedica Scandinavica. Supplementum.

[13]  O. Monge,et al.  Prognostic factors in bone sarcomas. , 1997, Acta orthopaedica Scandinavica. Supplementum.

[14]  O. Myklebost,et al.  Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. , 1997, British Journal of Cancer.

[15]  P. Ambros,et al.  Chromosomal aberrations in ewing tumors: An evaluation by conventional cytogenetics and in situ hybridization techniques , 1996 .

[16]  O. Delattre,et al.  Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Ishida,et al.  Fusion of an ETS‐family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy , 1996, Genes, chromosomes & cancer.

[18]  P. Houghton,et al.  Gonadal mixed germ cell tumor combined with a large hemangiomatous lesion. , 1995 .

[19]  S. Hilsenbeck,et al.  Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.

[20]  C. Denny,et al.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. , 1995, Oncogene.

[21]  S. Knuutila,et al.  Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. , 1995, Cancer research.

[22]  T. Visakorpi,et al.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. , 1995, Cancer research.

[23]  T. Triche,et al.  The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.

[24]  T. Triche,et al.  Comparison of Ewing's sarcoma of bone and peripheral neuroepithelioma. An immunocytochemical and ultrastructural analysis of two primitive neuroectodermal neoplasms. , 1994, Archives of pathology & laboratory medicine.

[25]  T. Triche,et al.  Combinatorial generation of variable fusion proteins in the Ewing family of tumours. , 1993, The EMBO journal.

[26]  C. Denny,et al.  The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 , 1993, Molecular and cellular biology.

[27]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[28]  M. Valentine,et al.  A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. , 1990, Cytogenetics and cell genetics.

[29]  A. Aurias,et al.  Chromosomes in Ewing's sarcoma. II. Nonrandom additional changes, trisomy 8 and der(16)t(1;16). , 1988, Cancer genetics and cytogenetics.

[30]  J. Thiery,et al.  Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). , 1988, Cancer genetics and cytogenetics.

[31]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[32]  T. Triche,et al.  Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  P. Picci,et al.  Localized Ewing's sarcoma of bone: ten years' experience at the Istituto Ortopedico Rizzoli in 124 cases treated with multimodal therapy. , 1985, European journal of cancer & clinical oncology.

[34]  A. Huvos.  Bone tumors, diagnosis, treatment, and prognosis , 1979 .